DA Davidson Increases Vital Farms (NASDAQ:VITL) Price Target to $52.00

Key Points

• DA Davidson has increased the price target for Vital Farms (NASDAQ:VITL) from $51.00 to $52.00, suggesting a potential upside of 13.56% from the stock's previous close.
• Vital Farms recently reported $0.36 EPS for the quarter, beating the consensus estimate of $0.27 by $0.09, with revenue increasing by 25.4% year-over-year to $184.77 million.
• A majority of analysts, at least eleven, have given Vital Farms a "buy" rating, leading to an average target price of $48.20 among them.

Vital Farms (NASDAQ:VITL - Get Free Report) had its target price upped by analysts at DA Davidson from $51.00 to $52.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a "buy" rating on the stock. DA Davidson's price objective would suggest a potential upside of 13.56% from the stock's previous close.

VITL has been the topic of a number of other research reports. Stifel Nicolaus upped their target price on shares of Vital Farms from $44.00 to $48.00 and gave the company a "buy" rating in a research note on Friday. Morgan Stanley lowered their target price on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Telsey Advisory Group upped their target price on shares of Vital Farms from $46.00 to $50.00 and gave the company an "outperform" rating in a research note on Friday. Lake Street Capital set a $60.00 price objective on shares of Vital Farms and gave the stock a "buy" rating in a research note on Friday. Finally, BMO Capital Markets reaffirmed an "outperform" rating on shares of Vital Farms in a research note on Friday. Eleven analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $48.20.

Vital Farms Stock Performance

Vital Farms stock traded up $0.31 on Monday, reaching $45.79. 538,135 shares of the stock were exchanged, compared to its average volume of 986,457. The stock has a market cap of $2.05 billion, a PE ratio of 40.88 and a beta of 0.94. The company has a current ratio of 2.48, a quick ratio of 2.10 and a debt-to-equity ratio of 0.02. Vital Farms has a twelve month low of $27.91 and a twelve month high of $46.34. The firm has a fifty day moving average price of $36.45 and a two-hundred day moving average price of $34.83.

Vital Farms (NASDAQ:VITL - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.09. Vital Farms had a net margin of 7.84% and a return on equity of 18.40%. The company had revenue of $184.77 million for the quarter, compared to the consensus estimate of $170.28 million. During the same quarter in the previous year, the firm posted $0.36 EPS. The business's revenue was up 25.4% compared to the same quarter last year. Sell-side analysts anticipate that Vital Farms will post 1.11 EPS for the current year.

Insider Activity at Vital Farms

In other Vital Farms news, insider Matthew Ohayer sold 30,000 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $39.17, for a total value of $1,175,100.00. Following the completion of the sale, the insider owned 6,858,890 shares of the company's stock, valued at approximately $268,662,721.30. This represents a 0.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Thilo Wrede sold 1,200 shares of the stock in a transaction on Friday, July 11th. The stock was sold at an average price of $38.97, for a total transaction of $46,764.00. Following the sale, the chief financial officer directly owned 56,187 shares of the company's stock, valued at $2,189,607.39. This represents a 2.09% decrease in their position. The disclosure for this sale can be found here. Insiders sold 67,400 shares of company stock worth $2,413,630 over the last 90 days. 21.30% of the stock is currently owned by company insiders.

Institutional Trading of Vital Farms

A number of hedge funds have recently modified their holdings of VITL. Caitong International Asset Management Co. Ltd increased its holdings in Vital Farms by 20,650.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,660 shares of the company's stock valued at $51,000 after buying an additional 1,652 shares during the period. US Bancorp DE grew its holdings in shares of Vital Farms by 36.2% during the 1st quarter. US Bancorp DE now owns 1,929 shares of the company's stock valued at $59,000 after purchasing an additional 513 shares during the last quarter. CWM LLC grew its holdings in shares of Vital Farms by 43.2% during the 1st quarter. CWM LLC now owns 2,154 shares of the company's stock valued at $66,000 after purchasing an additional 650 shares during the last quarter. Union Bancaire Privee UBP SA bought a new stake in shares of Vital Farms during the 1st quarter valued at approximately $112,000. Finally, Assetmark Inc. grew its holdings in shares of Vital Farms by 18.9% during the 2nd quarter. Assetmark Inc. now owns 3,153 shares of the company's stock valued at $121,000 after purchasing an additional 501 shares during the last quarter. Institutional investors and hedge funds own 98.59% of the company's stock.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.